一个质量改进计划,用于管理长期结构化的住所环境中,对于严重精神疾病的人来说,克洛扎宾诱导的便秘
Lori Arbutiski1, K N Roy Chengappa2, Ana Lupu3
1Western Psychiatric Hospital - UPMC, USA.
Archives of psychiatric nursing
|March 7, 2024
概括
这项质量改进项目提高了对精神分裂症患者和工作人员中克洛扎相关便秘的认识. 干预措施改善了肠道习惯和患者在克洛扎治疗期间的持续时间.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 提高质量 提高质量
背景情况:
- 克洛扎对于耐治疗精神分裂症至关重要,但未得到充分利用.
- 便秘是克洛扎宾的严重,医学上具有后果的副作用.
- 这种副作用可能是患者坚持治疗和维持治疗的重要障碍.
研究的目的:
- 提高护理人员和患者对克洛扎相关便秘的认识.
- 实施干预措施以减轻便秘的医疗后果.
- 为了改善患者在克洛沙平治疗中的保留.
主要方法:
- 一个质量改进项目 (QIP) 由护士,精神科医生和药剂师共同开发,并得到了患者的意见.
- 为工作人员和患者创建了教育材料,以及每日肠道运动日志 (BML).
- 干预措施包括在团队会议上审查BML,并应用药理和非药理策略.
主要成果:
- 患者从便秘中获得了缓解,并且改善了肠道习惯.
- 员工表现出更多的知识和适应的工作流程和实践.
- 患者和工作人员的反促进了教育材料和干预措施的完善.
结论:
- 提高意识,教育和对肠道习惯的持续监测是关键.
- 药理和非药理干预措施有效地管理与克洛扎相关的便秘.
- 解决便秘可以改善患者的留守时间,并最大限度地提高克洛沙平治疗的益处.
相关概念视频
01:21Drugs for Treatment of Constipation-Predominant IBS
163
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
163
01:26Psychosis: Goals of Pharmacotherapy
128
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
128
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
204
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
204
01:28Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
01:17Drugs for Treatment of Diarrhea-Predominant IBS
169
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
169
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
252
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
252